A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment

NCT02897115 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to slow recruitment.

Conditions

Axial Spondyloarthritis

Interventions

BIOLOGICAL: Adalimumab
OTHER: Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Sponsor

AbbVie

Collaborators

[object Object]
[object Object]
[object Object]